A double-blind, placebo-controlled study of sertraline with naltrexone for alcohol dependence

Drug and Alcohol Dependence

Volumn 99, Issue 1-3, 2009, Pages 317-321

  Farren, Conor K ^a,b   Scimeca, Michael ^b   Wu, Ran ^a   Malley, Stephanie O ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Alcohol dependence; Alcohol typology; Clinical trial; Naltrexone; Sertraline

Indexed keywords

ALCOHOL; NALTREXONE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; ALCOHOLISM; APPETITE DISORDER; ARTICLE; BEHAVIOR THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOUBLE BLIND PROCEDURE; DRINKING BEHAVIOR; DRUG DOSE INCREASE; DRUG EFFICACY; ENERGY; FEMALE; HEADACHE; HUMAN; LIBIDO DISORDER; MAJOR CLINICAL STUDY; MALE; NAUSEA; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SEXUAL DYSFUNCTION; SIDE EFFECT; SLEEP DISORDER; TREATMENT OUTCOME;

ADULT; AGE OF ONSET; ALCOHOLISM; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; ETHNIC GROUPS; FEMALE; HUMANS; MALE; MARITAL STATUS; MIDDLE AGED; NALTREXONE; NARCOTIC ANTAGONISTS; PATIENT COMPLIANCE; PATIENT SELECTION; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTHERAPY; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; TREATMENT OUTCOME;

EID: 57049087903     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2008.06.006     Document Type: Article

References (34)

1. Anton R., Moak D.H., and Latham P. The obsessive-compulsive drinking scale: a new method of assessing outcome in alcoholism treatment studies. Arch. Gen. Psychiatry 53 (1996) 225-231
2. Anton R., O'Malley S., Ciraulo D., Cisler R., Couper D., Donovan D., Hosking J., Johnson B., LoCastro J., Longabaugh R., Mason B., Mattson M., Miller W., Pettinati H., Randall C., Swift R., Weiss R., Williams L., and Zweben A. Combination pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized clinical trial. JAMA 295 (2006) 2003-2017
3. Beck A., Ward C., and Mendelson M. An inventory for measuring depression. Arch. Gen. Psychiatry 3 (1961) 461-471
4. Cornelius J., Salloum I., and Ehler J. Fluoxetine in depressed alcoholics: a double-blind, placebo-controlled trial. Arch. Gen. Psychiatry 54 (1997) 700-770
5. Del Boca F., Kranzler H., Brown J., and Korner P. Assessment of medication compliance through UV light detection of a riboflavin tracer. Alcohol Clin. Exp. Res. 20 (1996) 1412-1417
6. Farren C.K., Rezvani A.H., Overstreet D., and O'Malley S. Combination pharmacotherapy in alcoholism: a novel treatment approach. CNS Spectrums 5 (2000) 70-76
7. Garbutt J.C., et al. Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial. JAMA 293 13 (2005) 1617-1625
8. Gill K., Amit Z., and Koe B.K. Treatment with sertraline, a new serotonin uptake inhibitor, reduces voluntary ethanol consumption in rats. Alcohol 5 (1988) 349-354
9. Higgins G.A., Tomkins D.M., Fletcher P.J., and Sellers E.M. Effect of drugs influencing 5-HT function on ethanol drinking and feeding behavior in rats: studies using a drinkometer system. Neurosci. Biobehav. Rev. 16 (1992) 535-552
10. Johnson B., Ait-Daoud N., and Prihoda T. Combining ondansetron and naltrexone effectively treats biologically predisposed alcoholics: from hypothesis to preliminary clinical evidence. Alcohol Clin. Exp. Res. 24 (2000) 737-742
11. Keifer F., Jahn H., Tarnaske T., Helwig H., Briken P., Holzbach R., Kahn P., Stracke R., Baehr M., Naber D., and Wiedermann K. Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study. Arch. Gen. Psychiatry 60 (2003) 92-99
12. Kranzler H., Burleson J., Brown J., and Babor T. Fluoxetine treatment seems to reduce the beneficial effects of cognitive-behavioral therapy in type B alcoholics. Alcohol Clin. Exp. Res. 20 (1996) 1534-1541
13. Kranzler H., and Van Kirk J. Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis. Alcohol Clin. Exp. Res. 25 (2001) 1334-1341
14. Kranzler H.R., et al. Naltrexone depot for treatment of alcohol dependence: a multicenter, randomized, placebo-controlled clinical trial. Alcohol Clin. Exp. Res. 28 (2004) 1051-1059
15. Kranzler H., Mueller T., Cornelius J., Pettinati H.M., Moak D., Martin P.R., Anthenelli R., Brower K., O'Malley S., Mason B.J., Hasin D., and Keller M. Sertraline treatment of co-occurring alcohol dependence and major depression. J. Clin. Psychopharmacol. 26 (2006) 13-20
16. Le A., Poulos C., Harding S., Watchus J., Juzytsch W., and Shaham Y. Effects of naltrexone and fluoxetine on alcohol self-administration and reinstatement of alcohol seeking induced by priming injections of alcohol and exposure to stress. Neuropsychopharmacology 21 (1999) 435-444
17. LeMarquand D., Pihl R., and Benkelfat C. Serotonin and alcohol intake, abuse and dependence: clinical evidence. Biol. Psychiatry 36 (1994) 326-337
18. LeMarquand D., Pihl R., and Benkelfat C. Serotonin and alcohol intake, abuse and dependence: findings of animal studies. Biol. Psychiatry 36 (1994) 395-421
19. Mann K. Pharmacotherapy of alcohol dependence: a review of the clinical data. CNS Drugs 18 (2004) 485-504
20. McLellan A., Luborsky L., Woody G., and O'Brien C. An improved diagnostic instrument for substance abuse subjects: the addiction severity index. J. Nerv. Ment. Disorders 168 (1980) 26-33
21. Moak D.H., Anton R.F., Latham P.K., Voronin K.E., Waid R.L., and Durazo-Arvizu R. Sertraline and cognitive behavioral therapy for depressed alcoholics: results of a placebo-controlled trial. J. Clin. Psychopharmacol. 23 (2003) 553-562
22. O'Malley S., Jaffe A., Chang G., Schottenfeld R., Meyer R., and Rounsaville B. Naltrexone and coping skills therapy for alcohol dependence. Arch. Gen. Psychiatry 49 (1992) 881-887
23. O'Malley S.S., Garbutt J.C., Gastfriend D.R., Dong Q., and Kranzler H.R. Efficacy of extended-release naltrexone in alcohol-dependent patients who are abstinent before treatment. J. Clin. Psychopharmacol. 27 (2007) 507-512
24. O'Malley S.S., Robin R.W., Levenson A.L., GreyWolf I., Chance L.E., Hodgkinson C.A., Romano D., Robinson J., Meandzija B., Stillner V., Wu R., and Goldman D. Naltrexone alone and with sertraline for the treatment of alcohol dependence in Alaska Natives and non-Natives residing in rural settings: a randomized controlled trial. Alcohol Clin. Exp. Res. (2008) (published article online: 14-May-2008)
25. Pettinati H.M., O'Brien C.P., Rabinowitz A.R., Wortman S.P., Oslin D.W., Kampman K.M., and Dackis C.A. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking. J. Clin. Psychiatry 26 (2006) 610-625
26. Pettinati H., Volpicelli J., Kranzler H., Luck G., Rukstalis M., and Cnaan A. Sertraline treatment for alcohol dependence: interactive effects of medication and alcoholic subtype. Alcohol Clin. Exp. Res. 24 (2000) 1041-1049
27. Pettinati H., Volpicelli J., Luck G., Kranzler H., Rukstalis M., and Cnaan A. Double-blind clinical trial of sertraline treatment for alcohol dependence. J. Clin. Psychopharmacol. 21 (2001) 143-153
28. Project-Match R.G. Matching alcoholism treatment to client heterogeneity: project MATCH posttreatment drinking outcomes. J. Stud. Alcohol 58 (1997) 7-29
29. Rezvani A., Overstreet D., Mason G., Janowsky D., Hamedi M., Clarke E.J., and Yang Y. Combination pharmacotherapy: a mixture of small doses of naltrexone, fluoxetine, and a thyrotropin-releasing hormone analogue reduces alcohol intake in three strains of alcohol-preferring rats. Alcohol Alcohol. 35 (2000) 76-83
30. Sobell L., Sobell M., Leo G., and Cancill A. Reliability of a timeline method: assessing normal drinker reports of recent drinking and a comparative evaluation across several populations. Brit. J. Addict. 83 (1988) 393-402
31. Spitzer R., and Williams J. Structured Clinical Interview for DSM IV (1992), Biometric Research Department, New York State Psychiatric Institute, New York
32. Tiihonen J., Ryynanen O., Kauhanen J., Hakola H., and Salaspuro M. Citalopram in the treatment of alcoholism: a double-blind placebo-controlled study. Pharmacopsychiatry 29 (1996) 27-29
33. Volpicelli J., Alterman A., Hayashida M., and O'Brien C. Naltrexone in the treatment of alcohol dependence. Arch. Gen. Psychiatry 49 (1992) 876-880
34. Zink R.W., Rohrbach K., and Froehlich J.C. Naltrexone and fluoxetine act synergistically to decrease alcohol intake. Alcohol Clin. Exp. Res. 21 Suppl. (1997) 104A